๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

24 recruiting trials

for GEP-NET

DCEUS to Assess Treatment Response to PRRT in GEP-NET NCT07319416NA1 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: Vuebox 68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours NCT06155318n/a1 site๐Ÿ“ Milan IRCCS San Raffaele ยท Tests: 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors NCT06016855Phase 41 site๐Ÿ“ Nashville Vanderbilt-Ingram Cancer Center ยท Tests: Tumor Debulking, Lutetium Lu 177 Dotatate, Computed Tomography, Magnetic Resonance Imaging, Copper Cu 64 Dotatate A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET) NCT06505395Phase 21 site๐Ÿ“ Beijing CSPC ZhongQi Pharmaceutical Technology Co., Ltd. ยท Tests: SYHX2008 injection, Sandostatin LAR@ Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients NCT05701241Phase 419 sites๐Ÿ“ Brasschaat๐Ÿ“ Rumst๐Ÿ“ Ghent University Hospital, Antwerp ยท Tests: Somatostatin analog Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial NCT05773274Phase 242 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Tucson National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Cabozantinib, Computed Tomography, Everolimus, Lutetium Lu 177 Dotatate Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors NCT06441331Phase 17 sites๐Ÿ“ San Francisco๐Ÿ“ Cincinnati๐Ÿ“ Philadelphia ITM Solucin GmbH ยท Tests: Lutetium Lu 177-Edotreotide, Amino Acid Solution An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors. NCT05884255Phase 32 sites๐Ÿ“ Shanghai๐Ÿ“ Tianjin Jiangsu HengRui Medicine Co., Ltd. ยท Tests: Lutetium (177Lu) Oxodotreotide Injection๏ผ›long-acting Octreotide, long-acting Octreotide Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. NCT07165132Phase 114 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Iowa City RayzeBio, Inc. ยท Tests: RYZ401 Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors NCT04090034n/a2 sites๐Ÿ“ Dallas๐Ÿ“ Dallas Methodist Health System ยท Tests: Peptide Receptor Radionuclide Therapy Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs NCT06356467n/a1 site๐Ÿ“ Milan IRCCS San Raffaele Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors. NCT07150546Phase 12 sites๐Ÿ“ Atlanta๐Ÿ“ Atlanta Emory University ยท Tests: Stereotactic Body Radiation Therapy, Lutetium Lu 177 Dotatate, Computed Tomography, Magnetic Resonance Imaging, Galliumโ€ฆ Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy NCT06427798Phase 1, Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: 68Ga-DOTATATE, [203Pb]VMT-alpha-NET, [212Pb]VMT-alpha-NET A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM) NCT04893785Phase 21 site๐Ÿ“ Naples National Cancer Institute, Naples ยท Tests: Cabozantinib and Temozolomide Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!) NCT05196087n/a1 site๐Ÿ“ Toronto University Health Network, Toronto Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors NCT05636618Phase 1, Phase 220 sites๐Ÿ“ Jacksonville๐Ÿ“ Miami๐Ÿ“ Orlando Perspective Therapeutics ยท Tests: [203Pb]VMT-ฮฑ-NET, [212Pb]VMT-ฮฑ-NET A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients NCT07635316n/a1 site๐Ÿ“ East Hanover Novartis Pharmaceuticals Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET NCT06784752Phase 367 sites๐Ÿ“ Scottsdale๐Ÿ“ Fayetteville๐Ÿ“ Denver Novartis Pharmaceuticals ยท Tests: [177Lu]Lu-DOTA-TATE, Octreotide LAR Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET) NCT04086485Phase 1, Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Lu-177-DOTATATE, Olaparib, Ga dotatate scanning, FDG-PET scanning, Amino Acid infusion Spanish Series of Patients Treated With the Radionuclide Lutetium177 NCT04949282n/a20 sites๐Ÿ“ Santiago de Compostela๐Ÿ“ Granada๐Ÿ“ Palma de Mallorca Sociedad Espaรฑola de Medicina Nuclear e Imagen Molecular ยท Tests: Lutetium [177Lu] oxodotreotide/dotatate, Lutetium [177Lu] oxodotreotide/dotatate Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases NCT04837885Phase 24 sites๐Ÿ“ Bordeaux๐Ÿ“ Nรฎmes๐Ÿ“ Pessac University Hospital, Bordeaux ยท Tests: Positron emission tomography computed tomography (PET/CT) with Intra-hepatic (IAH) injection, Positron emission tomograโ€ฆ Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort NCT06256705NA5 sites๐Ÿ“ Clichy๐Ÿ“ Clichy๐Ÿ“ Nantes Assistance Publique - Hรดpitaux de Paris ยท Tests: Simultaneous 68Ga-DOTATOC PET-MRI Nutritional Status Assessment in Adult Patients Followed for Gastroenteropancreatic Neuroendocrine Tumors at Strasbourg University Hospital NCT07302100n/a1 site๐Ÿ“ Strasbourg University Hospital, Strasbourg, France PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial) NCT07185672Phase 32 sites๐Ÿ“ Mumbai๐Ÿ“ Navi Mumbai Tata Memorial Hospital ยท Tests: Peptide Receptor Radionuclide Therapy with Lu177 DOTATATE, Capecitabine plus temozolamide
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy